Argitalpenak (14) Noelia Romina Silva Pilipich argitalpenak

2024

  1. A Dual-Armed Oncolytic Virus Shows Clinical Efficacy in Advanced Solid Cancers

    Clinical Cancer Research, Vol. 30, Núm. 17, pp. 3649-3651

  2. DNA electroporation in a vacuum: A “shocking” innovation for vaccines

    Molecular Therapy Nucleic Acids

  3. Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies

    British Journal of Cancer, Vol. 130, Núm. 5, pp. 869-879

  4. Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19

    Vaccines, Vol. 12, Núm. 3

2023

  1. Checkpoint blockade meets gene therapy: Opportunities to improve response and reduce toxicity

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 43-86

  2. Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors

    Cancers, Vol. 15, Núm. 8

  3. Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses

    Cancer Letters, Vol. 561

2022

  1. Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma

    Molecular Therapy - Oncolytics, Vol. 26, pp. 246-264

  2. Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer

    Molecular Therapy - Nucleic Acids, Vol. 29, pp. 387-399

2021

  1. A small virus to deliver small antibodies: New targeted therapies based on AAV delivery of nanobodies

    Microorganisms, Vol. 9, Núm. 9

  2. Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. A new generation of vaccines based on alphavirus self-amplifying RNA

    Current Opinion in Virology, Vol. 44, pp. 145-153

  2. Long-term systemic expression of a novel pd-1 blocking nanobody from an aav vector provides antitumor activity without toxicity

    Biomedicines, Vol. 8, Núm. 12, pp. 1-19

2019

  1. Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses

    Molecular Therapy, Vol. 27, Núm. 11, pp. 1892-1905